Phosphoinositide 3-kinase and integrin signalling are involved in activation of Bruton tyrosine kinase in thrombin-stimulated platelets-Reference-Cited by-同舟云学术

Phosphoinositide 3-kinase and integrin signalling are involved in activation of Bruton tyrosine kinase in thrombin-stimulated platelets

Published:1999-01-22 Issue:1 Volume:443 Page:66-70
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:

Author:

Laffargue Muriel,Ragab-Thomas Jeannie M.F.,Ragab Ashraf,Tuech Joel,Missy Karine,Monnereau Laurent,Blank Ulrich,Plantavid Monique,Payrastre Bernard,Raynal Patrick,Chap Hugues

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/S0014-5793(98)01680-9/fullpdf

Reference38 articles.

1. Protein tyrosine phosphorylation and the adhesive functions of platelets

2. The Btk subfamily of cytoplasmic tyrosine kinases: structure, regulation and function

3. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases

4. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines

5. Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?;International Journal of Molecular Sciences;2021-02-28

2. Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution;Pharmacological Reviews;2020-03-20

3. Effect of Bruton's tyrosine kinase inhibitors on platelet aggregation in patients with acute myocardial infarction;Thrombosis Research;2019-07

4. Btk Inhibitors as First Oral Atherothrombosis-Selective Antiplatelet Drugs?;Thrombosis and Haemostasis;2019-05-14

5. Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque–triggered thrombus formation in humans;Blood;2018-06-14